Mukonzo, Jackson K <br/><br/>
Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.  [electronic resource] 

 -  PloS one  2014 
 - e86919 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0086919  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Adult<br/>Alkynes<br/>Area Under Curve<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Benzoxazines--pharmacokinetics<br/>Cyclopropanes<br/>Cytochrome P-450 CYP2B6<br/>Cytochrome P-450 CYP3A--genetics<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>Humans<br/>Lamivudine--therapeutic use<br/>Male<br/>Middle Aged<br/>Mutation<br/>Pharmacogenetics<br/>Reverse Transcriptase Inhibitors--pharmacokinetics<br/>Treatment Outcome<br/>Uganda<br/>Zidovudine--therapeutic use